Search - tctmd.com

Displaying 141 - 160 of 401

Sort: Relevancy | Date

News Industry News

Boston Scientific Announces U.S. FDA Approval for MRI Labeling on High-Voltage Devices and U.S. Launch of Resonate™ Devices with the HeartLogic™ Heart Failure Diagnostic

September 25, 2017

News Daily News

Acute MI Patients With Cancer History Less Likely to Get Evidence-Based Therapies

L.A. McKeown

September 25, 2017

News Daily News

Quitting Chronic, Low-Dose Aspirin May Boost Risk of Cardiovascular Events

Todd Neale

September 25, 2017

TAVR Takeover? Experts Debate Timing of Surgery’s Ousting in Aortic Stenosis

Shelley Wood

September 24, 2017

News Daily News

New Performance and Quality Metrics for STEMI and NSTEMI Care

Michael O'Riordan

September 21, 2017

News Daily News

New Guidelines for Cardiogenic Shock Push for Regionalized Care, More Research

Shelley Wood

September 21, 2017

News Daily News

Study Questions Incremental Benefit of Beta-Blockers After Acute MI

Michael O'Riordan

September 21, 2017

News Daily News

Carotid Revascularizations Declining as Outcomes Improve, Medicare Data Show

L.A. McKeown

September 20, 2017

News Conference News VIVA 2017

Low-Dose Paclitaxel DCB Shows Long-term Durability in Treating PAD

L.A. McKeown

September 18, 2017

News Daily News

Three New Positive PFO Closure Studies May Turn the Tide in Cryptogenic Stroke

Yael L. Maxwell

September 18, 2017

News Conference News VIVA 2017

ACT I: Women Reap More Long-term Benefits From Carotid Stenting vs CEA

L.A. McKeown

September 15, 2017

Presentation

Global Geographic Variation in Patient Characteristics in PCI Clinical Trials

September 15, 2017

News Industry News

New FOURIER Analysis Shows Repatha® (Evolocumab) Reduces Cardiovascular Events In Patients With Diabetes

September 15, 2017

News Features

COMPASS: All Signs Point to Big Impact in CAD and PAD, Experts Predict

Todd Neale

September 15, 2017

News Daily News

Patients in PCI Trials Vary Around the World, With Women Still Underrepresented

Michael O'Riordan

September 15, 2017

News Daily News

Hormone Therapy Doesn’t Impact Long-term All-Cause, CV, or Cancer Mortality: WHI Analysis

Caitlin E. Cox

September 14, 2017

News Daily News

Rivaroxaban, Warfarin Provide Similar Results Early After Mild Strokes Related to A-fib

Todd Neale

September 14, 2017

News Conference News VIVA 2017

EVAR Outcomes Equivalent Between Men and Women, Registries Show

L.A. McKeown

September 14, 2017

News Features

Absorb Vanishes, but Can Other Bioresorbable Scaffolds Make Magic Happen?

Michael O'Riordan

September 13, 2017

News Industry News

Medtronic IN.PACT Admiral DCB Global Two Year Data and IN.PACT SFA Four Year Data Presented in VIVA Late Breaking Clinical Trials

September 12, 2017

Advertisement

Boston Scientific Announces U.S. FDA Approval for MRI Labeling on High-Voltage Devices and U.S. Launch of Resonate™ Devices with the HeartLogic™ Heart Failure Diagnostic

Acute MI Patients With Cancer History Less Likely to Get Evidence-Based Therapies

Quitting Chronic, Low-Dose Aspirin May Boost Risk of Cardiovascular Events

TAVR Takeover? Experts Debate Timing of Surgery’s Ousting in Aortic Stenosis

New Performance and Quality Metrics for STEMI and NSTEMI Care

New Guidelines for Cardiogenic Shock Push for Regionalized Care, More Research

Study Questions Incremental Benefit of Beta-Blockers After Acute MI

Carotid Revascularizations Declining as Outcomes Improve, Medicare Data Show

Low-Dose Paclitaxel DCB Shows Long-term Durability in Treating PAD

Three New Positive PFO Closure Studies May Turn the Tide in Cryptogenic Stroke

ACT I: Women Reap More Long-term Benefits From Carotid Stenting vs CEA

Global Geographic Variation in Patient Characteristics in PCI Clinical Trials

New FOURIER Analysis Shows Repatha® (Evolocumab) Reduces Cardiovascular Events In Patients With Diabetes

COMPASS: All Signs Point to Big Impact in CAD and PAD, Experts Predict

Patients in PCI Trials Vary Around the World, With Women Still Underrepresented

Hormone Therapy Doesn’t Impact Long-term All-Cause, CV, or Cancer Mortality: WHI Analysis

Rivaroxaban, Warfarin Provide Similar Results Early After Mild Strokes Related to A-fib

EVAR Outcomes Equivalent Between Men and Women, Registries Show

Absorb Vanishes, but Can Other Bioresorbable Scaffolds Make Magic Happen?

Medtronic IN.PACT Admiral DCB Global Two Year Data and IN.PACT SFA Four Year Data Presented in VIVA Late Breaking Clinical Trials

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content